Lawrence Klein
Fortune : 54 M $ au 31/05/2026
Fortune : 54 M $ au 31/05/2026
Lawrence O. Klein est membre du conseil d'administration de Dyne Therapeutics, Inc. et directeur de l'exploitation et des affaires de CRISPR Therapeutics AG. Le Dr. Klein a précédemment occupé le poste de partenaire associé chez Mckinsey & Co. (Suisse). Le Dr Klein a obtenu un doctorat de l'université de Stanford et un diplôme de premier cycle de l'université du Wisconsin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,91 % | 15/06/2026 | 925 580 ( 1,91 % ) | 54 M $ | 31/05/2026 |
| 09/06/2026 | 70 ( 0 % ) | 1 473 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| JADE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 28/04/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01/02/2024 |
| JASPER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/06/2023 |
| DYNE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 24/05/2023 |
| CRISPR THERAPEUTICS AG | Directeur des opérations | 01/10/2022 |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | 01/02/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national